SCHEMBL9288013

SCHEMBL9288013

CCc1ccccc1-c1cc(Cl)ccc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 1/20 0.53
CSNK2B P67870 1/20 0.53
CSNK2A1 P68400 1/20 0.53
CSNK2A3 Q8NEV1 1/20 0.53
PTPN1 P18031 1/20 0.46
S1PR4 O95977 2/20 0.46
DPP4 P27487 1/20 0.44
S100A4 P26447 1/20 0.44
CNR2 P34972 1/20 0.40
CHRM1 P11229 1/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
CXCL8 P10145 1/20 0.39
CYP2C9 P11712 1/20 0.39
PTPN11 Q06124 1/20 0.39
ERCC5 P28715 1/20 0.38
FEN1 P39748 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRB2 P47870 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9289218 0.85 CSNK2A2 (0.66) CSNK2A2CSNK2BCSNK2A1CSNK2A3DPP4
SCHEMBL12653045 0.85 CSNK2A2 (0.49) CSNK2A2CSNK2BCSNK2A1CSNK2A3PTPN1
SCHEMBL9287839 0.82 DPP4 (0.63) CSNK2A2CSNK2BCSNK2A1CSNK2A3S1PR4
SCHEMBL23862755 0.80 CSNK2A2 (0.55) CSNK2A2CSNK2BCSNK2A1CSNK2A3S100A4
SCHEMBL9285164 0.80 ALDH1A1 (0.49) CSNK2A2CSNK2BCSNK2A1CSNK2A3ALDH1A1
SCHEMBL8819020 0.80 CSNK2A2 (0.48) CSNK2A2CSNK2BCSNK2A1CSNK2A3DPP4
SCHEMBL9285171 0.80 CSNK2A2 (0.48) CSNK2A2CSNK2BCSNK2A1CSNK2A3MAPT
SCHEMBL2393195 0.78 CXCL8 (0.43) PTPN1DPP4CNR2CHRM1ALDH1A1
SCHEMBL381603 0.78 PTPN1 (0.56) PTPN1DPP4S100A4CNR2ALDH1A1
SCHEMBL29983105 0.78 PTPN1 (0.56) PTPN1DPP4S100A4CNR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND SHIONOGI & CO., LTD. (JP) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND BACE1, STS, APP CSNK2A2 682/4885CSNK2B 358/4885CSNK2A1 613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.